deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

INCANNEX HEALTHCARE LIMITED (ASX.IHL)

ASX Announcements (courtesy of ASX)

2020202120222023

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names
CompanyFROMTO
INCANNEX HEALTHCARE LIMITED05/07/2020
IMPRESSION HEALTHCARE LIMITED31/10/201606/07/2020
MOUNT MAGNET SOUTH LIMITED03/12/201531/10/2016
MOUNT MAGNET SOUTH NL03/12/2015
Shareholder links

 

REGISTRY:
Computershare Investor Services
P.O. Box 43078 Providence, RI 02940-3078 United States of America
RegistryWebsite 

Company details
ISIN: AU000000IHL8
Address: Level 23, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000
Tel:  +61 (0) 422 180 317

Date first listed: 23/05/2007

Sector: Health Care Equipment & Services
Industry Group: XMJ
Activities: Pharmaceuticals

delisted at entity's request under Listing Rule 17.11

29/11/2023

we understand under a scheme of arrangement Incannex Healthcare Inc. acquired all of the issued securities in IHL (at 1 new share or option for every 100 existing shares or options - except small parcel holders will eventually receive cash) effectively re-domiciling to the US and with shares listed on NASDAQ - Computershare US is the registry

29/11/2023

The securities of Incannex Healthcare Limited will be suspended from quotation at the close of trading on Friday, 17 November 2023 under Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with ASIC approving the scheme of arrangement by which Incannex Healthcare Inc. will acquire all of the issued securities in IHL.

17/11/2023

The suspension of trading in the securities of Incannex Healthcare Limited will be lifted immediately following the release by IHL of an announcement regarding a material update regarding IHL's psychedelic program.

15/03/2023

Interim analysis of study data to date indicates that there is a greater than 85% chance (>85%, alpha error probability 0.05) of the study showing a statistically significant benefit for the psilocybin treatment arm versus the placebo treatment arm at the conclusion of the study period. An independent Data Safety Monitoring Board (DSMB) has reviewed data from Incannex's ongoing Phase 2 "PsiGAD" clinical trial and recommends no changes to study design. The trial team and DSMB have identified no safety concerns to date.

15/03/2023

The securities of Incannex Healthcare Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IHL, pending the release of an announcement regarding a material update regarding IHL's psychedelic program.

14/03/2023

name changed from Impression Healthcare Limited

06/07/2020
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    31/10/2023Peter Widdows510,954$0.066$33,842
    23/03/2018Alistair Blake35,000$0.033$1,140
    04/12/2017Kelvin Smith90,000$0.021$1,879
    02/06/2017Alistair Blake25,691$0.041$1,048
    24/05/2017Alistair Blake34,466$0.056$1,916

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Troy ValentineNon Exec Chairman13/12/2017
    Joel LathamManaging Director, CEO19/07/2018
    Lekhram ChangoerCTO28/06/2022
    Peter WiddowsNon Exec Director01/03/2018
    Robert B. ClarkDirector17/08/2022
    George AnastassovDirector28/06/2022
    Madhukar BhallaCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Sud AgarwalNon Exec Director25/07/201928/06/2022
    Alistair BlakeDirector20/10/201625/07/2019
    Matthew WestonManaging Director, CEO01/02/201619/07/2018
    Adam WellischIndependent Director03/04/201708/05/2018
    John WorsfoldDirector20/10/201612/12/2017
    Kelvin SmithDirector20/10/201612/12/2017
    Alec PismirisNon Exec Chairman02/08/201303/04/2017
    David LeavyDirector22/12/201420/10/2016
    Michael FennellDirector22/12/201420/10/2016
    Mark PittNon Exec Director26/10/201022/12/2014
    Patrick FlintNon Exec Director15/04/201122/12/2014
    Colin ChenuNon Exec Director14/09/201025/11/2013
    Phillip ShreeveCFO01/06/201101/10/2013
    Reginald GillardNon Exec Chairman15/04/201102/08/2013
    Matthew ShackletonManaging Director18/04/200810/02/2012
    Frederick McMurrayDirector26/07/200711/11/2010
    David G. SandersAlternate Director24/09/201002/10/2010
    Geoffrey MotteramDirector31/05/200616/09/2010
    Geoffrey NewmanNon Exec Chairman31/05/200611/09/2010
    John StockleyNon Exec Director31/05/200619/08/2009
    Phillip BotsisNon Exec Chairman31/05/200618/09/2008
    Andrew PatersonManaging Director14/11/200606/04/2008

    Date of first appointment, title may have changed.